Target intelligence / Profile preview

NAA40 pseudogene 1 (NAA40P1)

Target: NAA40P1
Molecular classification: Other (non-coding pseudogene)

Overview

NAA40 pseudogene 1 (NAA40P1) is annotated in genomic databases as a pseudogene related to N-Alpha-Acetyltransferase 40 (NAA40). NAA40 itself is an evolutionarily conserved epigenetic enzyme (histone N-terminal acetyltransferase), catalyzing the N-terminal acetylation of histones H4 and H2A and implicated in oncogenesis, cancer progression, chromatin remodeling, and potentially metabolic regulation[1][2][3][4][5]. However, NAA40P1 does not encode a functional protein and is not implicated as a therapeutic drug target. Key distinction: If your interest lies in therapeutic targeting, focus on N-Alpha-Acetyltransferase 40 (NAA40) rather than NAA40P1. NAA40 is a physiologically active target; NAA40P1 is not.

Other names: NAA40P1NAA40 pseudogene 1

Beyond the preview

Go deeper on NAA40 pseudogene 1 (NAA40P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAA40 pseudogene 1 (NAA40P1).

Explore the full profile